Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1205 of 5804
-
Robotic surgery gets a sense of touch: could force feedback speed lung recovery?
Disease control Recruiting nowThe purpose of this research is to study patient outcomes based on the use of Force Feedback instruments during robotic-assisted lung resection. Force Feedback technology describes the physical forces a surgeon senses when pushing and pulling structures inside the body during rob…
Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drug cocktail targets Hard-to-Treat stomach cancer
Disease control Recruiting nowThis is a multicenter, phase 2, open label study to evaluate safety, tolerability and efficacy of SHR2554 combined with other anti-tumor treatments in patients with advanced or metastatic gastric or gastroesophageal junction adenocarcinoma.
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 15:42 UTC
-
When to thin the blood after a stroke? new trial seeks answer
Disease control Recruiting nowThis study evaluates the safety and efficacy of early versus delayed initiation of direct oral anticoagulants (DOACs) in patients with acute ischemic stroke related to atrial fibrillation after emergency endovascular therapy (EVT).
Phase: NA • Sponsor: Capital Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New Immune-Chemo cocktail aims to shrink inoperable lung tumors
Disease control Recruiting nowThis study is a prospective, multicenter, open-label, single-arm Phase II clinical trial. The study recruits patients with stage III unresectable non-small cell lung cancer according to the 8th edition of the AJCC/UICC staging system. It aims to observe and evaluate the efficacy …
Phase: PHASE2 • Sponsor: Jiangsu Cancer Institute & Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New heart drug mavacamten tested in indian patients
Disease control OngoingThe purpose of this study is to evaluate the safety, tolerability and effectiveness of mavacamten in adults with obstructive hypertrophic cardiomyopathy in India.
Phase: PHASE4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Could two radiation doses beat five for prostate cancer?
Disease control Recruiting nowProstate cancer is a common cancer, and a significant cause of cancer death in men. There are many potentially curative treatment options for prostate cancers that have not spread. A relatively recent option is called prostate stereotactic ablative radiotherapy (SABR). SABR is a …
Phase: PHASE2 • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Brain wave breakthrough: could smart DBS shorten dystonia treatment tuning?
Knowledge-focused Recruiting nowThe goal of this clinical trial is to learn whether local field potential (LFP) signals recorded from the globus pallidus interna (GPi) using the Medtronic Percept™ deep brain stimulation (DBS) device can help optimize DBS programming for people with dystonia. The study will also…
Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
New drug cocktail targets rare spleen cancer in early trial
Disease control Recruiting now:The aim of this study was to analyze the safety and efficacy of Zanubrutinib, Obinutuzumab, and Lenalidomide (ZGR) in the Treatment of Newly Diagnosed Splenic B-cell Lymphoma with Prominent Nucleoli (SBLPN). The main questions it aims to explore the Preliminary Efficacy of the …
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Brain zaps for ADHD? new study tests iTBS in children
Symptom relief ENROLLING_BY_INVITATIONThe goal of this clinical trial is to learn if brain stimulation can help children ages 6 to 12 with attention-deficit/hyperactivity disorder (ADHD) improve their attention and self-control. The main questions it aims to answer are: Does intermittent theta burst stimulation (iTB…
Phase: NA • Sponsor: Neurolab Plus • Aim: Symptom relief
Last updated Jun 26, 2026 19:15 UTC
-
New Antibody-Drug conjugate targets Hard-to-Treat cancers
Disease control Recruiting nowThis is a multicenter, open-label FIH, Phase 1a (dose escalation), Phase 1b (dose expansion) and Phase 2 study in patients with advanced metastatic solid tumors refractory to standard treatment.
Phase: PHASE1, PHASE2 • Sponsor: MBrace Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Personalized cell therapy aims to tame type 1 diabetes in early trial
Disease control Recruiting nowThis is a 78-week single arm, multi-center, Phase 1 study to evaluate the safety, tolerability, cellular kinetics, and biomarker changes in C-peptide over time of GNTI-122, an investigational cell therapy manufactured from a participant's own blood cells in adult participants wit…
Phase: PHASE1 • Sponsor: GentiBio, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Balloon or scope? new trial seeks best fix for Kids' swallowing problem
Disease control Not yet recruitingTo compare the efficacy of balloon dilatation (BD) and per oral endoscopic myotomy (POEM) in improving the symptoms of children with achalasia in short and long term Presently most guidelines such as American Society for Gastrointestinal Endoscopy (ASGE) or European Society for G…
Phase: NA • Sponsor: Asian Institute of Gastroenterology, India • Aim: Disease control
Last updated Jun 26, 2026 16:49 UTC
-
New inhaled drug aims to keep bronchiectasis patients Flare-Up free
Disease control Recruiting nowThis study is a phase 2b, multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose range finding study designed to explore the efficacy, safety, and tolerability of 2 active treatment regimens of CSL787 (immunoglobulin G \[IgG\] inhalation solution) compare…
Phase: PHASE2 • Sponsor: CSL Behring • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New daily pill for kids with ADHD enters key trial
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and examine the safety of two doses of EB-1020 QD XR capsule administered once daily orally in pediatric ADHD patients.
Phase: PHASE2, PHASE3 • Sponsor: Otsuka Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Can a simple protein improve recovery from heated chemo surgery?
Disease control Recruiting nowIntroduction Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is considered as the standard of care for the treatment of peritoneal metastases. Cytoreductive surgery with HIPEC is characterized by large intra operative fluid shift secondary to su…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
VR hypnosis may calm Alzheimer's patients during bath time
Symptom relief Recruiting nowA device combining a virtual reality (VR) headset with hypnotic scenarios may represent an effective tool to reduce anxiety and opposition during hygiene care in patients with neurocognitive disorders presenting with behavioral and psychological symptoms. The primary objective o…
Phase: NA • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Bladder device gets Long-Term safety check
Disease control Recruiting nowProspective, multi-center, single-arm, post-approval study is designed to assess the long-term safety and efficacy data of the Neuspera Sacral Neuromodulation (SNM) System following commercial approval of the Neuspera SNM System. Participants in this study received intervention/…
Phase: NA • Sponsor: Neuspera Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New pill could tame overactive thyroid in Graves' disease
Disease control Recruiting nowThis is a parallel group, Phase 2, 2-arm study to measure the treatment effect and safety of rilzabrutinib dose 1 or rilzabrutinib dose 2 in participants with Graves' disease, with and without Graves' orbitopathy, aged 18 years or older. Study details include: * Screening perio…
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New pill aims to quiet heartburn without damaging the esophagus
Symptom relief Not yet recruitingThis study aims to evaluate the efficacy and safety of JP-1366 in Patients with NERD
Phase: PHASE3 • Sponsor: Onconic Therapeutics Inc. • Aim: Symptom relief
Last updated Jun 26, 2026 14:58 UTC
-
New eye drop shows promise for glaucoma patients in large trial
Disease control CompletedThis study is designed to see how safe and effective a new eye drop, called Reformulated PG324, is for lowering eye pressure in people with open-angle glaucoma (OAG) or ocular hypertension (OHT).
Phase: PHASE3 • Sponsor: Alcon Research • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC